The effects of gender on clinical and immunological response to antiretroviral therapy among people living with HIV in Ile-Ife, Nigeria

The effects of gender on clinical and immunological response to antiretroviral therapy among people living with HIV in Ile-Ife, Nigeria

Bibliographic Details
Main Authors:	Olaniyi E. Onayemi, Muphy M. Oripelaye, Olutomidimu Afolabi, Olatunde F. Olanrewaju
Format:	Article
Language:	English
Published:	Termedia Publishing House 2018-11-01
Series:	HIV & AIDS Review. International Journal of HIV-Related Problems
Subjects:	HIV gender HAART immune response
Online Access:	https://www.termedia.pl/The-effects-of-gender-on-clinical-and-immunological-response-to-antiretroviral-therapy-among-people-living-with-HIV-in-Ile-Ife-Nigeria,106,34356,1,1.html

Similar Items

The Evolving Pattern Of Primary Skin Cancers in Ile-Ife, Nigeria
by: Oripelaye Mufutau Muphy, et al.
Published: (2018-09-01)

Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study
by: Gebremicael G, et al.
Published: (2021-03-01)

Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia
by: Genet Gebrehiwet Hailu, et al.
Published: (2021-06-01)

Vitiligo on tribal mark: A demostration of Wolf’s isotopic response
by: Mufutau Muphy Oripelaye, et al.
Published: (2019-01-01)

Fixed drug eruption induced by Fixed drug eruption induced by Moringa oleifera Moringa oleifera leaf leaf extracts - A case report extracts - A case report
by: Fatai Olatunde Olanrewaju, et al.
Published: (2017-10-01)

Familial vitiligo in mother and child; the genetic theory connection
by: Muphy M. Oripelaye, et al.
Published: (2017-04-01)

At the helm of haart: The experience of biographical time among people living with hiv in Nigeria
by: Ayodeji Bayo Ogunrotifa
Published: (2021-01-01)

Determinants of discordant immune response in a cohort of human immunodeficiency virus-infected patients initiating antiretroviral therapy
by: Abdullahi Umar, et al.
Published: (2020-01-01)

Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
by: Wubetu AD, et al.
Published: (2021-04-01)

Effects of adherence to antiretroviral therapy on body mass index, immunological and virological status of Nigerians living with HIV/AIDS
by: S.A. Olowookere, et al.
Published: (2016-03-01)

Factors associated with clinical, immunological and virological responses in protease-inhibitor-experienced brazilian children receiving highly active antiretroviral therapy containing Lopinavir-Ritonavir
by: Daisy Maria Machado, et al.

Prevalence of depression in people living with HIV and AIDS at the Kalafong Provincial Tertiary Hospital Antiretroviral Clinic
by: Brett van Coppenhagen, et al.
Published: (2019-07-01)

Gender differences in clinical and immunological outcomes in South African HIV-infected patients on HAART
by: Maskew, Mhairi
Published: (2008)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
by: Mulugeta Melku, et al.
Published: (2020-08-01)

Efectos adversos del tratamiento antirretroviral en niños infectados por el virus de la inmunodeficiencia humana Adverse effects of antiretroviral treatment in children infected by the human immunodeficiency virus
by: Xiomara Usuga
Published: (2012-06-01)

The Prevalence and Pattern of Superficial Fungal Infections among School Children in Ile-Ife, South-Western Nigeria
by: Olaide Olutoyin Oke, et al.
Published: (2014-01-01)

Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria
by: Paul Columba Inyang-Etoh, et al.
Published: (2018-01-01)

Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa zone of Osun state, Nigeria
by: Muhammed O. Afolabi, et al.
Published: (2009-04-01)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
by: Phasomsap Chayapa, et al.
Published: (2011-10-01)

The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects
by: Faustina Nkechi Osuji, et al.
Published: (2018-12-01)

Factors Associated with Non-Adherence to Highly Active Antiretroviral Therapy among Children Living with HIV/AIDS from Two Centres in Nigeria - A mixed methods Cross-Sectional Study
by: S.A. Olowookere, et al.
Published: (2020-09-01)

Bezafibrate for the treatment of hypertriglyceridemia in HIV1-infected patients on highly active antiretroviral therapy
by: Juliana Geraix, et al.

Dyslipidemia in AIDS patients on highly active antiretroviral therapy
by: Max Weyler Nery, et al.

Influence of HIV Infection and Antiretroviral Therapy on Bone Homeostasis
by: María Victoria Delpino, et al.
Published: (2020-09-01)

Candida colonisation in asymptomatic HIV patients attending a tertiary hospital in Benin City, Nigeria
by: Newton O. Esebelahie, et al.
Published: (2013-03-01)

Ocular problems in brazilian patients with AIDS before and in highly active antiretroviral therapy (HAART) era
by: Marcia Lopes Rodrigues, et al.

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received
by: Motta Davide, et al.
Published: (2012-06-01)

Associação entre uso de álcool em indivíduos com AIDS e adesão ao tratamento antirretroviral: uma revisão da literatura Association between the usage of alcohol by HIV patients and the adherence to the antiretroviral drug treatment: a literature review
by: Samuel Robson Moreira Rego, et al.
Published: (2010-01-01)

Appropriate adherence to antiretroviral therapy in the Alto Paranaiba, Minas Gerais, Brazil
by: Gabriela de Oliveira Souza, et al.

Remission of HIV-associated myelopathy after highly active antiretroviral therapy
by: Fernandez-Fernandez F, et al.
Published: (2004-07-01)

Effect of antiretroviral therapy on survival of HIV/TB-infected patients in Ukraine
by: Mykhailo Andreychyn, et al.
Published: (2013-04-01)

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
by: Sempa Joseph, et al.
Published: (2012-09-01)

Impact of gender on response to highly active antiretroviral therapy in HIV-1 infected patients: a nationwide population-based cohort study
by: Thorsteinsson Kristina, et al.
Published: (2012-11-01)

Highly active antiretroviral therapy: Does it Sound toxic?
by: Katijah Khoza-Shangase
Published: (2011-01-01)

Lesões anorretais em pacientes HIV positivos usuários de terapia anti-retroviral de alta efetividade Anorrectal lesions in HIV-positive patients using highly active antiretroviral therapy
by: Manuel Retamozo-Palacios, et al.
Published: (2007-06-01)

Effect of highly active antiretroviral therapy on neutrophil/lymphocyte ratio using white rabbit
by: Evarista Odaburhine Osime, et al.
Published: (2017-01-01)

Individualization of antiretroviral therapy - Pharmacogenomic aspect
by: Bhavik Dalal, et al.
Published: (2015-01-01)

Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study
by: Meybeck Agnes, et al.
Published: (2012-09-01)

Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
by: Flávia Marinho Sant'Anna, et al.

The impact of comorbid clinical depression on the health-related quality of life of adults on highly active antiretroviral therapy in Maiduguri, northeastern Nigeria
by: Ibrahim Abdu Wakawa, et al.
Published: (2014-01-01)